Search

everythinglearnresearchcommunity

for

Search:↓

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Moxibustion may help improve ovarian function by changing androgen levels.

A man with testotoxicosis was fertile despite low FSH levels, suggesting high testosterone may allow sperm production without FSH.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Excess androgens may cause PCOS, not just be a symptom.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

A new method can almost perfectly distinguish adenomyosis from similar conditions using blood tests.

Certain MC4R gene variants are linked to higher BMI in obese women with PCOS but do not cause PCOS.

New treatments for PCOS focus on managing symptoms and improving fertility.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.